Impaired Cell-Cleanup Is a Predictor of Postpartum Depression, Cornell Study Finds

Autophagy, the process by which the body recycles damaged cell parts into fully functioning cell parts, may be dampened in women with postpartum depression, according to a recent Cornell Weill study done in collaboration with John Hopkins University School of Medicine and the University of Virginia Health.  

Weill Scientists Reach New Heights With Multiple Sclerosis Drug Treatment

On Feb. 8, a new study on the multiple sclerosis drug siponimod conducted by researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center was published in Nature Communications. The study analyzed the drug’s shape and interactions in the body, allowing researchers to understand how to lessen the drug’s side effects, such as heart and liver problems, during treatment for MS patients. 

Weill Scientists Make Strides in Understanding Gut Microbiota

Cornell Weill scientists have recently developed a pipeline which creates direct access to singular genes of the organisms within the gut microbiome, advancing the foundational understanding of diseases within the human body as these singular genes can be manipulated and their effects observed.